1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc
XNAS: SPRY
8.39 0.09 (1.08%)
1.1M
XNAS Volume

XNAS 06 Apr, 2026 4:00 PM (EDT)

Watchlist

Portfolio

Alert

ARS Pharma Inc - SPRY - stock price prediction, stock price target, analyst ratings from 6 analysts

ARS Pharma Inc has a share price target of US$ 27, revenue growth forecast of 90.2%, and profit growth estimate of 12.9% for FY26, based on top 6 analyst calls.